Nouscom will join & present at the SITC 2019

Nouscom will join & present at the SITC 2019 from November 6-10.

Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium

Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium on October 22, 2019 in Basel.

Nouscom is presenting at the TMB & Neoantigen Congress

Nouscom will present at the TMB & Neoantigen Congress from October 10-11, 2019 in London.

Dr. Marina Udier, COO of Nouscom, will give a talk about our company at the BaselArea.swiss Life Science Event on June 20, 2019 in Basel

The BaselArea.swiss Life Science event will have Dr. Marina Udier, COO of Nouscom, talking about the story of the company and sharing insights and learnings along the way.

Nouscom will present at the NeoAg Summit 2018

The 3rd NeoAg Summit is the leading end-to-end industry- focused meeting dedicated to advancing neoantigen-based cancer vaccines and cell therapies. Download the full program of NeoAg Summit 2018.

Nouscom will present at the World Vaccine Congress Europe 2018

Find out the full program here: https://www.terrapinn.com/conference/world-vaccine-congress-europe/agenda.stm  

Nouscom will present at Biocapital Europe

Find out the full program here: http://www.biocapitaleurope.com

NousCom presents at Agenda Sachs Forum

Full program: http://www.sachsforum.com/uploads/5/1/9/6/51964431/17thbef-finalagenda.pdf

NousCom presents at 3rd CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE

Mainz, Germany Abstract Title: Great Apes Adenovirus neoantigens vaccine synergizes with immunomodulators in mouse models of cancer.

NousCom presents at 3rd Annual Immuno-Oncology BD&L and Investment Forum

EMBL Heidelberg, Germany Full program: https://am.asco.org

page 1 of 2